The vaccine, known as Ad5-nCoV, was jointly developed by the Beijing Biotechnology Institute, part of the Chinese government’s Academy of Military Medical Sciences, and the vaccine company CanSino Biologics.
However, US observers have questioned the claims, noting that the EPL is one of the largest standing armies in the world, making it statistically unlikely that its personnel have not been exposed to the virus.
Neither the Chinese government nor CanSino have said how widely the vaccine will be distributed, which units were selected, or whether it will be mandatory or voluntary for staff.
CNN contacted CanSino to comment on the announcement.
According to a CanSino statement, clinical trials of the new vaccine have shown a “good safety profile” with initial results indicating that Ad5-nCoV had the potential to prevent disease caused by SARS-CoV-2, the coronavirus strain that Covid-19 cause.
China is just one of several countries rushing to produce a vaccine for the new coronavirus, which has now infected more than 10.3 million people worldwide and killed at least 505,000.
According to CanSino’s statement, the first and second phases of their Ad5-nCoV vaccine trials have already been completed.